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Anthocyanins may play an important role in atherosclerosis prevention. However, the structure–
function relationships are not well understood. The objective of this study was to compare the
inhibitory effect of 21 anthocyanins against oxidized low-density lipoprotein-induced endothelial
injury to understand the relationship between anthocyanin chemical structure and the endothelial
protective properties, measured as cell viability, MDA production and NO release. Additionally, the
intracellular anti-radical activity of the selected anthocyanins was investigated to identify the cor-
relation with endothelial protection. Our results provide evidence that the number of –OH in total
or in B-ring, 30,40-ortho-dihydroxyl and 3-hydroxyl are the main structural requirements of antho-
cyanins in suppressing oxidative stress-induced endothelial injury and such inhibitory effect was
signiﬁcantly correlated with the intracellular radical scavenging activity.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction (–OCH ) substitutions on the ﬂavan nucleus and the structuralAnthocyanins belong to the widespread class of phenolic com-
pounds collectively named ﬂavonoids, which present in a wide
range of fruits, vegetables and beverages, including wine, tea or bil-
berry extract. Anthocyanins possess two benzene rings joined by a
linear three carbon chain (C2, C3, C4), represented as the C6–C3–C6
system (Fig. 1). Chemically, anthocyanins are polyhydroxylated or
polymethoxylated glycosides of anthocyanidins (aglycone of corre-
sponding anthocyanin) which are oxygenated derivatives of 2-
phenylbenzopyrylium or ﬂavylium salts, and approximately 400
individual anthocyanins have been identiﬁed in nature [1–3].
Anthocyanins exhibit different hydroxyl (–OH) or methoxylchemical Societies. Published by E
; AS, atherosclerosis; oxLDL,
ulfoxide; DMEM, Dulbecco’s
A, butylated hydroxyanisole;
0-dichloroﬂuorescein; CCK-8,
xide; MFI, mean ﬂuorescence
n-1; LOX-1, lectin-like oxLDL
oside; gal, galacoside; diglc,
i).3
variations are mainly due to differences in the number of –OHmoi-
eties in the molecule, the degree of methylation of –OH moieties,
the nature and the number of the sugar moiety attached to the
aglycone molecule and the speciﬁc position of these attachments.
Recently, epidemiological studies have suggested that cardio-
vascular diseases such as atherosclerosis (AS) can be decreased
by moderate wine consumption, particularly red wine, due to its
high content of phenolic compounds, including mainly anthocya-
nins [4,5]. Oxidative stress, mainly induced by oxidized low-den-
sity lipoprotein (oxLDL), induces the lipid peroxidation, changes
the secretory activities, increases the intracellular radicals produc-
tion, reduces the antioxidant capability and disturbs the nitric
oxide (NO) synthesis in endothelium, so that it appears to be the
crucial roles in the process of AS [6–10]. Some anthocyanins,
including delphinidin, cyanidin, cyanidin-3-glc, peonidin-3-glc
are reported to inﬂuence the function of endothelial cells and exert
inhibitory effect on oxidative injury in endothelial cells [11–13].
Reports also suggested that a minor modiﬁcation in the structure
can considerably result in a major change of the effects on endo-
thelial cells. With large numbers of anthocyanins widely discov-
ered in the edible plants, it is unclear what molecular
characteristics of anthocyanins are required for their protective ef-
fects on endothelial cells. Furthermore, the antioxidant and radicallsevier B.V. All rights reserved.
 Substituted position  The No. of -OH No. Compound  name 
C3’  C4’  C5’  C3  C5  C6 
 
In total A-ring B-ring C-ring 
1 Cyanidin  -OH -OH -H -OH -OH -H  5 2 2 1 
2 Peonidin  -OCH3 -OH -H -OH -OH -H  4 2 1 1 
3 Malvidin  -OCH3 -OH -OCH3 -OH -OH -H  4 2 1 1 
4 Pelargonidin -H -OH -H -OH -OH -H  4 2 1 1 
5 Cyanidin-3-glc -OH -OH -H -O-glc -OH -H  4 2 2 0 
6 Delphinidin-3-glc -OH -OH -OH -O-glc -OH -H  5 2 3 0 
7 Malvidin-3-glc -OCH3 -OH -OCH3 -O-glc -OH -H  3 2 1 0 
8 Pelargonidin-3-glc -H -OH -H -O-glc -OH -H  3 2 1 0 
9 Petunidin-3-glc -OH -OH -OCH3 -O-glc -OH -H  4 2 2 0 
10 Cyanidin-3-gal -OH -OH -H -O-gal -OH -H  4 2 2 0 
11 Malvidin-3-gal -OCH3 -OH -OCH3 -O-gal -OH -H  3 2 1 0 
12 Cyanidin-3,5-diglc -OH -OH -H -O-glc -O-glc -H  4 2 2 0 
13 Cyanidin-3-rut  -OH -OH -H -O-rut -OH -H  4 2 2 0 
14 Luteolinidin -H -OH -H -H -OH -H  4 2 2 0 
15 Fisetinidin -OH -OH -H -OH -H -H  4 1 2 1 
16 Diosmetinidin  -OH -OCH3 -H -H -OH -H  3 2 1 0 
17 Apigeninidin  -H -OH -H -H -OH -H  3 2 1 0 
18 Delphinidin  -OH -OH -OH -OH -OH -H  6 2 3 1 
19 Quercetagetinidin  -OH -OH -H -OH -OH -OH  6 3 2 1 
20 Peonidin-3-glc -OCH3 -OH -H -O-glc -OH -H  3 2 1 0 
21 Petunidin  -OH -OH -OCH3 -OH -OH -H  5 2 2 1 
Fig. 1. Chemical structures and molecular characteristics of anthocyanins tested in our study. Glucoside (glc), galacoside (gal), diglucoside (diglc), rutinoside (rut).
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sively demonstrated previously, however, the intracellular radical
scavenging capacity of various anthocyanins have not been
throughly elucidated [14–16].
In our study, 21 anthocyanins (Fig. 1) were choosed to compare
their inhibitory effects on oxLDL-induced endothelial injury, a pro-
cess important in the development of AS, and tried to identify the
structural requirements for the effects. Additionally, the intracellu-
lar radical scavenging activity of anthocyanins were investigated in
order to ﬁnd the correlation between the endothelial protection
and anti-radical capacity of anthocyanins.
2. Materials and methods
2.1. Anthocyanins and other chemicals
Twenty-one kinds of anthocyanins were purchased from Poly-
phenols Laboratories AS (Sandnes, Norway), Extrasynthese (Lyon,France) and Sigma–Aldrich (St. Louis, MO, USA), respectively, and
dissolved in dimethylsulfoxide (DMSO). Cell culture media Dul-
becco’s modiﬁed Eagle’s medium (DMEM) and fetal bovine serum
(FBS) were both purchased from Hyclone Laboratories (Logan,
UT). Butylated hydroxyanisole (BHA), (+)-a-tocopherol, and 20,70-
dichloroﬂuorescin diacetate (DCFH-DA) were all purchased from
Sigma–Aldrich. Cell counting kit (CCK-8) was purchased from Doj-
indo Laboratories (Kumamoto, Japan). Malondialdehyde (MDA)
and NO assay kits were both purchased from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). Human LDL (d = 1.019–
1.210 g/ml) was isolated in Sun Yat-Sen University (Guangzhou,
China), and CuSO4-oxidized LDL (2 mg protein/ml) was prepared
and provided by Dr. Ling [17].
2.2. Cell culture
Human vascular endothelial cell line EA.hy926 was kindly
provided by Dr. Liang [18]. Cells were grown in DMEM medium
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and 10% FBS at 37 C under a humidiﬁed atmosphere with 5%
CO2/95% air.
2.3. Cell viability measurement
Cell viabilitywas assessedbyCCK-8assay as described previously
[19]. Brieﬂy, cells were suspended at a ﬁnal concentration of
1  104 cells/well and cultured in 96-well ﬂat-bottomedmicroplate.
Then cells were preincubated for 2 h with culture medium contain-
ing various anthocyanins or (+)-a-Tocopherol and BHA (both as the
positive control) of different concentration (50 lM, 100 lM,
150 lM and 200 lM), Control and solvent control groups were
treated with culture medium and medium containing DMSO with
the ﬁnal concentration less than 0.2%, respectively. After preincuba-
tion, the culture supernatant was removed and the cells were
washed twicewith the serum-freemedium. Then, cellswere exposed
to culture medium containing oxLDL of 100 lg/ml for another 24 h
except the control and solvent control group. After removing the
culture supernatant, CCK-8 (10 ll) was added to each well contain-
ing 100 ll of culture medium and the plate was incubated for 2 h
at 37 C. Viable cells were counted by absorbance measurements at
450 nm using a monochromator microplate reader (Saﬁre II, Tecan,
Switzerland). The OD450 value was proportional to the degree of cell
viability. All experiments were performed in triplicate on three
separate occasions and the data are presented as mean of triplicate.
2.4. Determination of MDA production and NO release
As the indicator of endothelial cell injury, MDA and NO were
both detected with an assay kit according to manufacturer’s
instruction. Brieﬂy, after the cells were preincubated for 2 h with
various anthocyanins of 100 lM and treated with oxLDL of
100 lg/ml for another 24 h, the supernatant was collected from
each well. (+)-a-tocopherol and BHA were both set as the positive
control. Then, the MDA production and NO release were deter-
mined by measuring the optical density at 532 nm and 550 nm
by the microplate reader, respectively, and both expressed as
micromole per liter. Similar experiment was repeated three times
and the data are presented as mean of triplicate.
2.5. Intracellular radical scavenging activity measurement
The intracellular radicals of endothelial cells were evaluated by
using the non-polar DCFH-DA dye. The dye diffuses in the cells, gets
trapped by deacetylation, and in the presence of free radicals be-
comes oxidized to yield 20,70-dichloroﬂuorescein (DCF) [20]. The
intensity of ﬂuorescence reﬂected the enhanced oxidative stress.
DCFH-DA was dissolved in 5 mM DMSO and stored at 4 C accord-
ing to the procedure of Festa et al. [21]. After the incubation studies
as described before, endothelial cells whichwere previously seeded
in 24-well plates, were washed with non-serum medium. The ﬂuo-
rescence probe was added to the cells (3  104 cells/well) to a ﬁnal
concentration of 10 lM. After incubated with DCFH-DA at 37 C for
2 h, the ﬂuorescence intensity of DCFwasmeasured using a FLX 800
microplate ﬂuorescence reader (Biotech Instruments Inc., USA)
with the excitation and emission wavelengths set at 480 nm and
530 nm, respectively. The mean ﬂuorescence intensity (MFI) was
calculated with IPP 6.0 software and the intracellular radical level
was proportional to MFI. Similar experiment was repeated three
times and the data are presented as mean of triplicate.
2.6. Statistical analysis
The results shown are the mean ± S.E. of at least three indepen-
dent experiments (involving three to ﬁve observations for eachtreatment). Statistical analysis was performed by one-way analysis
of variance. If statistical signiﬁcance was reached for analysis of
variance (P < 0.05), Tukey–Kramer was applied as post-hoc test.
And the correlation between groups was evaluated by Pearson’s
correlation analysis.3. Results
3.1. Relationship between the molecular structure and the inhibitory
effect of anthocyanins on oxLDL-induced endothelial injury
In this study, 21 anthocyanins (Fig. 1) were choosed to investi-
gate the inhibitory effects on oxLDL-induced endothelial injury by
measuring cell viability, MDA production and NO release. We
found that except for quercetagetinidin (Table 1 and Supplemen-
tary data), the remaining 20 anthocyanins could inhibit oxLDL-in-
duced decrease of cell viability at various degree, and the
inhibitory effect became intensiﬁed as the concentration increased.
Since compared to oxLDL-treated group, most of the tested antho-
cyanins showed signiﬁcant effect (P < 0.05) over 100 lM, MDA and
NO level were both measured based on the pretreatment of differ-
ent anthocyanins at 100 lM. And we also found that except for
quercetagetinidin (Table 1 and Supplementary data), the remain-
ing anthocyanins showed inhibitory effect on oxLDL-induced in-
crease of MDA production and decrease of NO release at various
degree. In our study, delphinidin and delphinidin-3-glucoside were
found to be the most potent anthocyanidin and anthocyanin in the
inhibition of endothelial injury, respectively (Table 1 and Supple-
mentary data). By Pearson’s correlation analysis, a signiﬁcant cor-
relation was observed between the effect of 21 anthocyanins
(100 lM) on cell viability and MDA production (correlation coefﬁ-
cient (r) = 0.925, P < 0.01), cell viability and NO release (r = 0.980,
P < 0.01), MDA production and NO release (r = 0.935, P < 0.01)
(Supplementary data).
As shown in Fig. 1, the total number of –OH substitutions of
the remaining 20 anthocyanins (except for quercetagetinidin)
ranges from 3 to 6. The results shown in Fig. 2 demonstrate that
the relationship between –OH moieties in total or in B-ring and
the inhibitory effect (the effect on cell viability, MDA production
and NO release) of anthocyanins are all linear, which implied that
the more –OH moieties present in total or in B-ring, the higher
the inhibitory effect of anthocyanins on endothelial oxidative
injury.
As shown in Table 2, our results suggested that the inhibitory
effect of anthocyanins on oxLDL-induced endothelial injury may
rather closely related to the different positions of various substitu-
ents than the number of –OH moieties. Paired comparison analysis
was applied to observe the effect of different substituents (–H, –
OH, –OCH3, –O-glc, –O-gal, –O-rut, –O-diglc) and positions (C30,
C40, C50, C3, C5, C6) on oxLDL-induced cell viability, MDA produc-
tion and NO release of endothelial cells. Generally, the results ap-
proved that hydroxylation at C30, C40 and C3 signiﬁcantly
increased the inhibitory effects (Table 2i, ii, iv), while hydroxyl-
ation at C6 signiﬁcantly attenuated the effects (Table 2vi). Both
of methylation at C30 or C40 and glycosylation at C3 decreased
the effects (Table 2i, ii, iv), while hydroxylation and methylation
at C50 or hydroxylation and glycosylation at C5 showed no signiﬁ-
cant inﬂuence on the effects of anthocyanins (Table 2iii and v).
With the comparison among different sugar moieties attached to
the aglycone, as shown in Table 2iv and v, we found that the inhib-
itory effect of anthocyanins with monosaccharose substitution
(–glc or –gal) wasmuch stronger than those with disaccharose sub-
stitution (–diglc or –rut). However, we have found no signiﬁcant
difference between anthocyanins with glucoside and galacotoside
substitution, respectively.
Table 1
Effect of anthocyanins on cell viability, MDA production and NO release of oxLDL-induced EA.hy926 cells. Cells were pretreated with anthocyanins of 100 lM, respectively, and
then treated with oxLDL of 100 lg/ml. Cell viability was determined by absorbance measurement at 450 nm (OD450) with CCK-8 kits. MDA production and NO release were both
expressed as micromole per liter by their respective detection kits. BHA and (+)-a-tocopherol of 100 lM were both set as the positive control group.
Chemicals Cell viability (OD450)a MDA production (lM)b NO release(lM)c
Control 0.910 ± 0.073 3.880 ± 0.836 94.105 ± 15.680
0.2% DMSO 0.892 ± 0.022 3.728 ± 0.914 91.101 ± 11.948
100 lg/ml oxLDL 0.479 ± 0.062##,4 51.259 ± 3.161##,4 44.913 ± 11.414##,4
Delphinidin-3-glucoside 0.578 ± 0.059** 31.337 ± 1.378** 61.887 ± 6.828**
Delphinidin 0.744 ± 0.065** 24.946 ± 1.455** 81.160 ± 11.960
Quercetagetinidin 0.385 ± 0.034##,4 53.470 ± 3.593##,4 39.296 ± 11.193##,4
BHAd 0.670 ± 0.056** 27.393 ± 1.011** 71.834 ± 8.999**
(+)-a-Tocopherole 0.652 ± 0.073** 27.382 ± 0.685** 70.116 ± 8.912**
All of the data are expressed as the means ± S.E. of three independent experiments.
a Effect of anthocyanins on cell viability of oxLDL-induced EA.hy926 cells.
b Effect of anthocyanins on MDA production of oxLDL-induced EA.hy926 cells.
c Effect of anthocyanins on NO release of oxLDL-induced EA.hy926 cells.
d BHA (100 lM), the positive control group.
e (+)-a-Tocopherol (100 lM), the positive control.
** P < 0.01, vs. oxLDL (100 lg/ml) treated group.
## P < 0.01, vs. the control group.
4 P < 0.05, vs. BHA (100 lM) treated group.
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Fig. 2. Correlation between the number of –OH groups of anthocyanins and the effect on oxLDL-induced injury of EA.hy926 cells. The symbols represent 20 anthocyanins
(except for quercetagetinidin), respectively. Data were analyzed by Pearson’s correlation coefﬁcient (r) and Fisher’s r to z (p) about 20 anthocyanins.
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endothelial injury and the intracellular radical scavenging activity of
anthocyanins
The intracellular radical scavenging activity was determined by
measuring the intensity of DCF ﬂuorescence. When DCFH-DA-la-
beled cells were incubated in the medium for 2 h, a sudden incre-
ment in ﬂuorescence intensity indicated the oxidation of DCFH-DA
by intracellular radicals (Fig. 3 and Supplementary data). It is foundthat except quercetagetinidin, the remaining 20 anthocyanins re-
duced oxLDL-induced increase of DCF ﬂuorescence at various de-
gree, while quercetagetinidin showed a reverse action. The
comparatively more effectual anthocaynins used in our study in-
cluded delphinidin, cyanidin, petunidin, peonidin, ﬁsetinidin, lute-
olinidin, delphinidin-3-glc, cyanidin-3-glc, malvidin-3-glc,
cyanidin-3,5-diglc, most of which were structurally hydroxylated
at C30, C40 and C3. A signiﬁcant linear correlation was observed be-
tween the inhibitory effects of anthocyanins on oxLDL-induced
Table 2
Inﬂuence of changing substituents of anthocyanins on cell viability, MDA production and NO release of oxLDL-induced injury of EA.hy926 cells.
Changing substituents Paired comparison Signiﬁcance of difference
A B Cell viability MDA production NO release
(i) C30
–H? –OH Pelargondin ? Cyanidin " ; "**
Pelargondin-3-glc ? Cyanidin-3-glc " ; "
Apigeninidin ? Luteolinidin "** ; "**
–OH? –OCH3 Cyanidin ? Peonidin ;** " ;**
Cyanidin-3-glc ? Peonidin-3-glc ; " ;
Petunidin ? Malvidin ;** " ;*
Petunidin-3-glc ? Malvidin-3-glc ; "* ;
–H? –OCH3 Pelargondin ? Peonidin ; " ;
Pelargondin-3-glc ? Peonidin-3-glc ; " "
(ii) C40
–OH? OCH3 Luteolinidin ? Diosmetinidin ;** " ;**
(iii) C50
–H? –OH Cyanidin ? Delphindin " ; "
Cyanidin-3-glc ? Delphindin-3-glc " ; "
–OH? –OCH3 Delphindin ? Petunidin ; " ;
Delphindin-3-glc ? Petunidin-3-glc ; " ;
–H? –OCH3 Cyanidin ? Petunidin ; " ;
Cyanidin-3-glc ? Petunidin-3-glc ; " ;
Peonidin ? Malvidin " " ;
Peonidin-3-glc ? Malvidin-3-glc " " ;
(iv) C3
–H? –OH Luteolinidin ? Cyanidin "* ; "
Apigeninidin ? Pelargonidin " ; "
–OH? O-glc Cyanidin ? Cyanidin-3-glc ;** " ;**
Delphinidin ? Delphindin-3-glc ;** " ;**
Petunidin ? Petunidin-3-glc ;** " ;**
Malvidin ? Malvidin-3-glc ;** " ;
Peonidin ? Peonidin-3-glc ;** " ;
Pelargondin ? Pelargondin-3-glc ;* " ;
–OH? –O-gal Cyanidin ? Cyanidin-3-gal "** ; "**
–OH? –O-rut Cyanidin ? Cyanidin-3-rut "** ; "**
–O-glc? –O-gal? –O-rut Cyanidin-3-glc ? Cyanidin-3-gal ; " ;
Cyanidin-3-glc ? Cyanidin-3-rut ;** " "*
Cyanidin-3-gal ? Cyanidin-3-rut ; " "
(v) C5
–H? –OH Fisetinidin ? Cyanidin " ; "
–OH? –O-glc Cyanidin-3-glc ? Cyanidin-3,5-diglc ; " ;
(vi) C6
–H? –OH Cyanidin ? Quercetagetinidin ;** "** ;**
": A < B; ;: A > B.
Glucoside (glc), galacoside (gal), diglucoside (diglc), rutinoside (rut).
* P < 0.05.
** P < 0.01, A vs. B in paired comparison.
L. Yi et al. / FEBS Letters 584 (2010) 583–590 587endothelial injury and the intracellular radical scavenging activity.
AS shown in Fig. 4, the correlation coefﬁcient (r) between the effect
on cell viability and intracellular radical scavenging activity, MDA
production and intracellular radical scavenging activity, NO release
and intracellular radical scavenging activity were 0.897(P < 0.01),
0.997(P < 0.01) and 0.906(P < 0.01), respectively.4. Discussion
Recently, the protective effect of anthocyanins on endothelial
cells have widely been studied and were sparked interest as poten-
tial therapeutic agents against a wide variety of diseases involving
radical damages including AS [22,23]. Some anthocyanins such as
delphinidin, cyanidin, and petunidin have been reported to inﬂu-ence the proliferation and cell cycle distribution of endothelial
cells, and to regulate the expression of some AS-related genes
including endothelin-1 (ET-1) and nitric oxide synthase (eNOS)
[24–26]. However, few studies have been focused on the inhibitory
effect of anthocyanins on oxidative injury in endothelial cells.
Endothelial injury, mainly by oxLDL, is commonly considered as
playing a pivotal role in AS development both in the early stages
of lesion formation, and later in the disease progression process
by inducing atherosclerotic plaque unstability [27]. It has been
widely recognized that oxLDL is a major risk factor for the develop-
ment of AS, and thus inhibition of oxLDL-induced endothelial in-
jury might be helpful for the prevention and treatment of AS.
Anthocyanins belong to the kind of ﬂavonoids, with minor differ-
ence in the chemical structure. Flavonoids may be divided into sev-
eral subclasses, i.e., ﬂavones (and isoﬂavones), ﬂavanones,
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Although numerous studies have focused on the structure–activity
relationship of ﬂavonoids (except for anthocyanins) in endothelial
protection [29–31], very little research is gained into the structural
requirement of anthocyanins. In this study, we found that the
number of –OH in total or on B-ring, 30,40-ortho-dihydroxyl on B-
ring and a 3-hydroxyl group on C-ring appeared to be the main
structural requirements of anthocyanins for the inhibitory effects
on the oxidative injury in endothelial cells. Our study might pro-
vide a basis for the design of novel AS preventive agents. This is
the ﬁrst report of the structure–activity relationship of anthocya-
nins for inhibitors of endothelial injury induced by oxLDL.
Recently, lectin-like oxLDL receptor-1 (LOX-1) was found to be a
new kind of oxLDL receptor and was believed to be the main recep-
tor for oxLDL. Studies have revealed that LOX-1 mediates oxLDL-induced apoptosis and oxidative injury in human coronary artery
endothelial cells [32]. Intracellular reactive oxygen species (ROS),
a second messenger, has been demonstrated to be involved in
oxLDL-induced oxidative injury in endothelial cells [33–36]. And
it is demonstrated that the increase of intracellular ROS could
not only result in the oxidative injury directly, but also induce
the expression of some targeted genes (eNOS, blc-2, bax, etc.)
through the activation of NF-kappaB indirectly [35]. So impairment
of intracellular ROS generation induced by oxLDL might be an
effective way to inhibit endothelial injury. In our study, we found
that anthocyanins, particularly with the molecular characteristics
of 30,40-ortho-dihydroxyl on B-ring or a 3-hydroxyl group on C-ring
appeared to manifest an effectual intracellular anti-radical activity.
And a signiﬁcant linear correlation between the anti-radical
activity of anthocyanins and the inhibitory effect of endothelial
L. Yi et al. / FEBS Letters 584 (2010) 583–590 589oxidative injury have been found. Therefore, it is guessed that
anthocyanins might inhibit the lipid peroxidation and MDA pro-
duction, or induce the expression of eNOS and the release of NO,
both through the inhibition of ROS generation. That is, anthocya-
nins might exert endothelium-protective effect through the radial
scavenging mechanism, especially through the highly signiﬁcant
contribution of the C30,C40-ortho-dihydroxyl and C3-hydroxylation.
The 30,40-ortho-dihydroxyl structure of B-ring is an important
determinant for antioxidative potential because it confers a higher
degree of stability to the ﬂavonoid (including anthocyanins) phe-
noxyl radicals by participating in electron delocalization [37–40].
And substitution (methylation or glycosylation) of C3-OH could af-
fect the planarity of the molecule, causing B-ring to lose coplana-
rity to A-ring and C-ring [41]. It has been determined that the
torsion angle of B-ring with the rest of the ﬂavonoid (including
anthocyanins) molecule can be correlated with its overall scaveng-
ing activity [42]. Substitution of C3–OH with a methyl group or su-
gar residues could increase the torsion angle of B-ring with the rest
of the molecule, causing a loss of coplanarity and decreased conju-
gation. Our results also inferred that C6–OH may enhance the
prooxidation activity of anthocyanins, which might result in the
aggravation of oxLDL-induced endothelial injury, however, the
mechanism is unknown.
Numerous studies have clearly shown that anthocyanins can
enter into the circulation intact [43–47]. Anthocyanins were
mainly absorbed and excreted in intact forms and metabolized into
methylated derivatives in human urine, although there is a rather
low bioavailability [48]. Recently, It has been revealed that antho-
cyanins could be incorporated into the plasma membrane and
cytosol of endothelial cells and may be beneﬁcial for scavenging
of various oxidative stressors [49]. It is widely accepted that
oxLDL-induced endothelial injury is associated with an alteration
of the cell redox status, thus the pre-incorporation of anthocyanins
by endothelial cells might enhance their resistance to the after-
wards damaging effects resulted from ROS generation induced by
oxLDL. Although there is very little knowledge about the different
bio-absorption and bioavailability of different anthocyanins in
endothelial cells, it is supposed that the signiﬁcant correlation be-
tween the inhibition of endothelial oxidative injury and intracellu-
lar radical scavenging activity of anthocyanins could be based upon
anthocyanin incorporation by endothelial cells.
In summary, our study revealed the structural requirements of
anthocyanins for the protective potency against oxLDL-induced
endothelial injury and presumed that anthocyanins may exert such
effect through the intracellular radical scavenging pathway. The re-
sults of the present study might provide some evidence for AS pre-
vention and help to provide a basis for the design of potent anti-
atherosclerotic agents that will have therapeutic potential in the
prevention of AS.
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